Thrombin increases hyposmotic taurine efflux and accelerates ICI-swell and RVD in 3T3 fibroblasts by a src-dependent EGFR transactivation

Pflugers Arch. 2008 Feb;455(5):859-72. doi: 10.1007/s00424-007-0343-y. Epub 2007 Sep 27.

Abstract

The present study in Swiss3T3 fibroblasts examines the effect of thrombin on hyposmolarity-induced osmolyte fluxes and RVD, and the contribution of the src/EGFR pathway. Thrombin (5 U/ml) added to a 30% hyposmotic medium markedly increased hyposmotic 3H-taurine efflux (285%), accelerated the volume-sensitive Cl- current (ICI-swell) and increased RVD rate. These effects were reduced (50-65%) by preventing the thrombin-induced intracellular Ca2+ [Ca2+]i rise with EGTA-AM, or with the phospholipase C (PLC) blocker U73122. Ca2+calmodulin (CaM) and calmodulin kinase II (CaMKII) also participate in this Ca2+-dependent pathway. Thrombin plus hyposmolarity increased src and EGFR phosphorylation, whose blockade by PP2 and AG1478, decreased by 30-50%, respectively, the thrombin effects on hyposmotic taurine efflux, ICI-swell and RVD. Ca2+- and src/EGFR-mediated pathways operate independently as shown by (1) the persistence of src and EGFR activation when [Ca2+]i rise is prevented and (2) the additive effect on taurine efflux, ICI-swell or RVD by simultaneous inhibition of the two pathways, which essentially suppressed these events. PLC-Ca2+- and src/EGFR-signaling pathways operate in the hyposmotic condition and because thrombin per se failed to increase taurine efflux and ICI-swell under isosmotic condition it seems that it is merely amplifying these previously activated mechanisms. The study shows that thrombin potentiates hyposmolarity-induced osmolyte fluxes and RVD by increasing src/EGFR-dependent signaling, in addition to the Ca2+-dependent pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cell Size*
  • Chloride Channels / physiology
  • Chlorides / metabolism*
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Enzyme Inhibitors / pharmacology
  • ErbB Receptors / metabolism
  • Estrenes / pharmacology
  • Hemostatics / metabolism*
  • Hemostatics / pharmacology
  • Mice
  • Osmotic Pressure / drug effects
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Pyrimidines / pharmacology
  • Pyrrolidinones / pharmacology
  • Quinazolines
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Swiss 3T3 Cells
  • Taurine / pharmacokinetics*
  • Thrombin / metabolism*
  • Thrombin / pharmacology
  • Tritium
  • Tyrphostins / pharmacology
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / metabolism

Substances

  • AG 1879
  • Chloride Channels
  • Chlorides
  • Enzyme Inhibitors
  • Estrenes
  • Hemostatics
  • Phosphodiesterase Inhibitors
  • Pyrimidines
  • Pyrrolidinones
  • Quinazolines
  • Tyrphostins
  • Tritium
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • RTKI cpd
  • Taurine
  • Egtazic Acid
  • EGTA acetoxymethyl ester
  • ErbB Receptors
  • src-Family Kinases
  • Thrombin
  • Calcium